> News


Viglya wishes to establish transparent and open communication with its stakeholders. This section offers new and updated information regarding the company and the life science sector.

UK MHRA: Drug Safety Update (January 2019)

Medical Device Alerts issued in December 2018 A notice was issued by Allergan about the availability of textured breast implants in the UK. Letters and drug alerts sent to healthcare professionals in December 2018 In [...]

Find out why Viglya is your strategic partner in drug development.Read more